About
ZELTIQ Aesthetics is a medical technology company based in Pleasanton, California, specializing in non-invasive fat reduction through its patented cryolipolysis process, marketed as CoolSculpting. Founded in 2005 and renamed in 2007, ZELTIQ became a subsidiary of AbbVie after acquisitions by Allergan in 2017 and AbbVie in 2020. The CoolSculpting system is ZELTIQ's flagship product, utilizing controlled cooling to freeze and eliminate fat cells without surgery. This treatment is designed for body contouring and is offered by medical professionals, including clinics, dermatologists, and plastic surgeons. The technology is based on research from Massachusetts General Hospital, highlighting its effectiveness as a non-invasive alternative to liposuction. ZELTIQ has established a strong position in the cash-pay body contouring market, appealing to individuals seeking fat reduction without the need for surgery or downtime.
Technologies
Keywords
Company Information
-
Employees 95
-
Founded 2005
-
Annual Revenue $342100000
-
Total Funding $161400000
Location
4410 Rosewood Drive, Pleasanton, California, United States, 94588